type 2 diabetic patients with NAFLD/NASH
Conditions
Interventions
dietand ergotherapy and or (alpa-GI, Met) and sugra.
diet and ergotherapy and/or (alpa-GI,Met) +DPP-4 blocker.
Sponsors
Saga University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Diet and exercise therapy plus or minus oral diabetes agent therapy, for example a-GI or metformin, for more than 12 weeks. The condition is the following HbA1c is more than 6.5 2.Patients with NASH or NAFLD diagnosed by using the guideline defined by JGH 3.Age is no fewer than 80, nor more than 20 4.Sex is female or male 5.Consenting patients
Exclusion criteria
Exclusion criteria: 1.Ppatients with diabetes 2.Patients with past history of ovascular lesion or stroke 3.Patients with past history of allergy 4.Patients with the necessity of IRI therapy 5.Patients with past history of liver disorder or renal dysfunction 6.Inadequacy of usingig this therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of patients decreasing of HbA1c>0.5% and not gaining weight gain 72 weeks after administration. | — |
Countries
Japan
Contacts
Public ContactHirokazu Takahashi
Saga University internal Medicine
Outcome results
None listed